Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
Open accessThe DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
Genetic studies have shown that the tuberous sclerosis complex (TSC) 1–TSC2–mammalian target of Rapamycin (mTOR) and the Hippo–Yes-associated protein 1 (YAP) pathways are master regulators of organ size, which are often involved in tumorigenesis. The crosstalk between these signal transduction pathways in coordinating environmental cues, such as nutritional status and mechanical constraints, is crucial for tissue growth. Whether and how mTOR regulates YAP remains elusive. Here we describe a novel mouse model of TSC which develops renal mesenchymal lesions recapitulating human perivascular epithelioid cell tumors (PEComas) from patients with TSC. We identify that YAP is up-regulated by mTOR in mouse and human PEComas. YAP inhibition blunts abnormal proliferation and induces apoptosis of TSC1–TSC2-deficient cells, both in culture and in mosaic Tsc1 mutant mice. We further delineate that YAP accumulation in TSC1/TSC2-deficient cells is due to impaired degradation of the protein by the autophagosome/lysosome system. Thus, the regulation of YAP by mTOR and autophagy is a novel mechanism of growth control, matching YAP activity with nutrient availability under growth-permissive conditions. YAP may serve as a potential therapeutic target for TSC and other diseases with dysregulated mTOR activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cross-talk also exists between Tsc1 and Tsc2 and the Hippo effector Yap as Tsc1/2-deficient cells have higher Yap levels due to less Yap degradation via the autophagosome system (83).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609 · cited 1×
“…mTORC1 inhibits the initiation of autophagy, which is a eukaryotic catabolic pathway that sequesters cellular organelles and proteins in double-membrane autophagosomes, and delivers and degrades the cargos in lysosomes (He and Klionsky, 2009; Mizushima and Komatsu, 2011; Choi et al., 2013).”
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 1×
“It is mainly through heterodimeric GTPases RagA/B and RagC/D, which were anchored to lysosomes through Ragulator protein complex (Lamtor1-5) and v-ATPase (Sancak et al., 2010; Sancak et al., 2008; Zoncu et al., 2011).”
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653 · cited 1×
“differentiate into adipocytes and smooth muscle cells in vitro, which are two major components commonly observed in angiomyolipomas (Armulik et al., 2011).”
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Cited by
Items 101–200 of 219
Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells
Wang, J., Filippakis, H., Hougard, T. R., Du, H., Ye, C., Liu, H.-J., Zhang, L., Hindi, K. M., Bagwe, S., Nijmeh, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101268118 · Cited by 33
Self-citationXu, D., Lv, J., He, L., Fu, L., Hu, R., Cao, Y., & Mei, C. (2018) · The FASEB Journal · doi:10.1096/fj.201701376rr · Cited by 33
A drug screening assay on cancer cells chronically adapted to acidosis
Pellegrini, P., Serviss, J. T., Lundbäck, T., Bancaro, N., Mazurkiewicz, M., Kolosenko, I., Yu, D., Haraldsson, M., D’Arcy, P., Linder, S. T., et al. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0645-5 · Cited by 32
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
Pulito, C., Korita, E., Sacconi, A., Valerio, M., Casadei, L., Sardo, F. L., Mori, F., Ferraiuolo, M. A., Grasso, G., Maidecchi, A., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1352-3 · Cited by 32
YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
Benedetto, G. D., Parisi, S., Russo, T., & Passaro, F. (2021) · Metabolites · doi:10.3390/metabo11030154 · Cited by 32
Arregui, C. D. L. C., Plata-Gómez, A. B., Deleyto-Seldas, N., García, F., Ortega-Molina, A., Abril-Garrido, J., Rodriguez, E., Nemazanyy, I., Tribouillard, L., Martino, A. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23857-8 · Cited by 32
Self-citationYAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers
Sardo, F. L., Canu, V., Maugeri‐Saccà, M., Strano, S., & Blandino, G. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188756 · Cited by 31
Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells
Gonçalves, A. F., Adlesic, M., Brandt, S., Hejhal, T., Harlander, S., Sommer, L., Shakhova, O., Wild, P. J., & Frew, I. J. (2017) · Nature Communications · doi:10.1038/s41467-017-01514-3 · Cited by 31
mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model
Polchi, A., Magini, A., DiMeo, D., Tancini, B., & Emiliani, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051474 · Cited by 25
Targeting ERK-Hippo Interplay in Cancer Therapy
Vališ, K., & Novák, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093236 · Cited by 31
Wu, J., Lu, W., & Cui, L. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4460 · Cited by 30
Quan, C., Sun, J. L., Lin, Z., Jin, T., Dong, B., Meng, Z., & Piao, J. (2019) · Cancer Management and Research · doi:10.2147/cmar.s202342 · Cited by 30
Chao, X., Wang, S., Ma, X., Zhang, C., Qian, H., Williams, S. N., Sun, Z., Peng, Z., Liu, W., Li, F., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000373 · Cited by 30
Self-citationCrosstalk between the mTOR and Hippo pathways
Honda, D., Okumura, M., & Chihara, T. (2023) · Development Growth & Differentiation · doi:10.1111/dgd.12867 · Cited by 30
Tian, Q., Fan, X., Ma, J., Han, Y., Li, D., Jiang, S., Zhang, F., Guang, H., Shan, X., Chen, R., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115261 · Cited by 29
Zhu, S., Wang, X., Chen, H., Zhu, W., Li, X., Cui, R., Yi, X., Chen, X., Li, H., & Wang, G. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002727 · Cited by 28
The role of Hippo‐YAP/TAZ signaling in brain development
Terry, B. K., & Kim, S. (2022) · Developmental Dynamics · doi:10.1002/dvdy.504 · Cited by 27
Wu, J., Cui, L., Yuan, J., Wang, Y., & Shu, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6224 · Cited by 27
Zhang, M., Tao, W., Yuan, Z., & Liu, Y. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14154 · Cited by 26
Dysregulation of YAP by ARF Stimulated with Tea-derived Carbon Nanodots
Xie, Y., Sun, Q.-L., Nurkesh, A., Jiang, L., Kauanova, S., Feng, J., Tursynkhan, D., Yang, Q., Kassymbek, A., Karibayev, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16441-y · Cited by 26
Pei, T., Luo, B., Huang, W., Liu, D., Li, Y., Xiao, L. Y., Huang, X. H., Ouyang, Y., & Zhu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.813165 · Cited by 25
Liu, Z., Lin, L., Zhu, H., Wu, Z., Ding, X., Hu, R., Jiang, Y., Tang, C., Ding, S., & Guo, R. (2021) · Cells · doi:10.3390/cells10113069 · Cited by 25
Vinexin contributes to autophagic decline in brain ageing across species
Park, S. J., Frake, R. A., Karabiyik, C., Son, S. M., Siddiqi, F. H., Bento, C. F., Sterk, P., Vicinanza, M., Tanasa, M. P., & Rubinsztein, D. C. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00903-y · Cited by 24
Tang, F., & Christofori, G. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1806450 · Cited by 24
Strepkos, D., Markouli, M., Papavassiliou, K. A., Papavassiliou, A. G., & Piperi, C. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12762 · Cited by 23
Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
Lin, K. C., Park, H. W., & Guan, K. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050202 · Cited by 22
Rozengurt, E., & Eibl, G. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i15.1797 · Cited by 22
Tao, L., Chen, X., Zheng, Y., Wu, Y., Jiang, X., You, M., Li, S., & Hu, F. (2021) · Molecules · doi:10.3390/molecules26092803 · Cited by 22
Zhang, N., Xue, M., Sun, T., Yang, J., Pei, Z., & Qin, K. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1973045 · Cited by 21
TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β
Ogórek, B., Lam, H. C., Khabibullin, D., Liu, H.-J., Nijmeh, J., Triboulet, R., Kwiatkowski, D. J., Gregory, R. I., & Henske, E. P. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy073 · Cited by 20
Self-citationHao, Y., Feng, D., Ye, H., & Liao, W. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300529 · Cited by 19
The role of YAP in the control of the metastatic potential of oral cancer
Ahmad, U. S., SARAVANAN, K., & Wan, H. (2021) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.026085 · Cited by 18
Barker, B. E., Hanlon, M. M., Marzaioli, V., Smith, C. M., Cunningham, C. C., Fletcher, J. M., Veale, D. J., Fearon, U., & Canavan, M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1029021 · Cited by 18
YAP in development and disease: Navigating the regulatory landscape from retina to brain
Zhao, Y., Sun, B., Fu, X., Zuo, Z., Qin, H., & Yao, K. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116703 · Cited by 18
Park, S., Ryu, W., Kim, T. Y., Hwang, Y., Han, H. J., Lee, J. D., Kim, G. M., Sohn, J., Kim, S. K., Kim, M. H., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01210-5 · Cited by 17
Mechanoautophagy: Synergies Between Autophagy and Cell Mechanotransduction at Adhesive Complexes
Ravasio, A., Morselli, E., & Bertocchi, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.917662 · Cited by 17
Shao, M., Shen, Y. L., Sun, H.-J., Meng, D., Huo, W., & Qi, X. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00634 · Cited by 17
Dan, W., Fan, Y., Hou, T., Wei, Y., Liu, B., Que, T., Yu, B., Zeng, J., & Li, L. (2022) · Journal of Cancer · doi:10.7150/jca.63514 · Cited by 15
The hippo pathway provides novel insights into lung cancer and mesothelioma treatment
Liu, X., Zuo, R. M., & Ou, W. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2727-0 · Cited by 15
Gao, Y., Zhang, X., Xiao, L., Zhai, C., Yi, T., Wang, G., Wang, E., Ji, X., Hu, L., Shen, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236013 · Cited by 15
Zhong, W., Jiang, H., Zou, Y., Ren, J., Li, Z., He, K., Zhao, J., Zhou, X., Mou, D., & Cai, Y. (2020) · Pediatric Research · doi:10.1038/s41390-020-0863-0 · Cited by 15
Matarrese, P., Vona, R., Ascione, B., Cittadini, C., Tocci, A., & Mileo, A. M. (2023) · Cells · doi:10.3390/cells12071048 · Cited by 13
Analysis of Altered Micro RNA Expression Profiles in Focal Cortical Dysplasia IIB
Li, L., Liu, C., Li, T., Guan, Y., Zhou, J., Qi, X., Yang, Y., Deng, J., Xu, Q., & Luan, G. (2015) · Journal of Child Neurology · doi:10.1177/0883073815609148 · Cited by 13
The Hippo pathway: a renewed insight in the craniofacial diseases and hard tissue remodeling
Chen, J., Cheng, J., Zhao, C., Zhao, B., Mi, J., & Li, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63305 · Cited by 13
Camacho‐Magallanes, A., Delaney, S. P., Lian, E. Y., Wiljer, E., Yockell‐Lelièvre, J., Julian, L. M., Pietrobon, A., Batoff, W., Kristof, A. S., & Stanford, W. L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/683359 · Cited by 13
Asrani, K. V., Mendes, A. A. D. A., Woo, J., Abadchi, S. N., Vidotto, T., Imada, E. L., Skaist, A. M., Feng, K., Liu, H. B., Kasbe, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63885-2 · Cited by 12
Pleniceanu, O., Shukrun, R., Omer, D., Vax, E., Kanter, I., Dziedzic, K., Pode‐Shakked, N., Mark‐Danieli, M., Pri‐Chen, S., Gnatek, Y., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201506111 · Cited by 12
The paradox of autophagy in Tuberous Sclerosis Complex
Reis, L. B., Filippi‐Chiela, E. C., Ashton‐Prolla, P., Visioli, F., & Rosset, C. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0014 · Cited by 11
Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy
Zhu, J., Wu, T., & Lin, Q. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08329-0 · Cited by 10
Qiao, Y., Xia, Q., Cao, X., Xu, J., Qiao, Z., Wu, L., Chen, Z., Yang, L., & Lu, X. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03043-5 · Cited by 10
Lymphangioleiomyomatosis: New Treatment Perspectives
Radzikowska, E. (2015) · Lung · doi:10.1007/s00408-015-9742-6 · Cited by 10
Cho, J., Weinstein, D. A., & Lee, Y. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12267 · Cited by 9
Frtús, A., Smolková, B., Uzhytchak, M., Lunová, M., Jirsa, M., Hof, M., Jurkiewicz, P., Lozinsky, V. I., Wolfová, L., Petrenko, Y., et al. (2020) · Pharmaceuticals · doi:10.3390/ph13120430 · Cited by 9
Nuclear localization of YAP in pancreatic cancer: More players besides Hippo pathway
Xie, Y., Qin, C. Y., Zhang, X., Li, Z., Zhao, B., Li, T., Zhao, Y., Yan, Y., Shi, H., Huang, L., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217864 · Cited by 8
Saini, H., Choudhary, M., Sharma, H., Chowdhury, S., Mukherjee, S., & Chowdhury, R. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08072-y · Cited by 8
Nezhad, F. Y., Riermeier, A., Schönfelder, M., Becker, L., de Angelis, M. H., & Wackerhage, H. (2022) · Transgenic Research · doi:10.1007/s11248-021-00293-4 · Cited by 8
Wan, X., He, H., Jialing, L., Wu, Y., Zhong, G., & Xu, X. (2023) · PubMed Central · doi:10.7518/hxkq.2023.2022382 · Cited by 7
Dill, P. E., Liang, N., & Pende, M. (2015) · Rare Diseases · doi:10.1080/21675511.2015.1016701 · Cited by 7
Self-citationPKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte
Zhao, D., Gao, Y., Wang, W., Pei, H., Xu, C., & Zhao, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111742 · Cited by 7
Regulation of YAP by mTOR and autophagy reveals a therapeutic target of Tuberous Sclerosis Complex
Pende, M., Liang, N., Zhang, C., Dill, P. E., Panasyuk, G., Pion, D., Koka, V., Gallazzini, M., Olson, E. N., Lam, H. C., et al. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.2071oia181 · Cited by 7
Self-citationYAP enters the mTOR pathway to promote tuberous sclerosis complex
Liang, N., & Pende, M. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2014.998100 · Cited by 7
Self-citationThe complexity of biological control systems: An autophagy case study
Tanasa, M. P., Tanasa, R., Park, S. J., & Rubinsztein, D. C. (2022) · BioEssays · doi:10.1002/bies.202100224 · Cited by 6
Tuberous Sclerosis Complex Kidney Lesion Pathogenesis: A Developmental Perspective
Pietrobon, A., & Stanford, W. L. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000146 · Cited by 6
Dai, C., Zhang, Y., Gong, Y., Bradley, A. T., Tang, Z., Sellick, K., Shrestha, S., Spears, E., Covington, B. A., Stanley, J. E., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111447 · Cited by 6
Regulation of Yes-Associated Protein by Laminar Flow
Chitragari, G., Shalaby, S. Y., Sumpio, B. J., Kurita, J., & Sumpio, B. E. (2018) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2018.03.002 · Cited by 6
Qi, Y., Jiao, Y.-L., Chen, P., Zhu, Q.-Q., Guo, R., Wu, D., Du, Y., Li, W.-Y., Cheng, Y.-Y., Wu, X.-S., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111974 · Cited by 5
Xu, J., Liu, K., Wang, F., & Su, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-25618-9 · Cited by 5
Liu, H., Lin, Z., Guo, Y., Zhou, Y., & Li, W. (2024) · Pharmaceuticals · doi:10.3390/ph17101352 · Cited by 5
Nguyen, A. V. P., Berger, B. H., Abdullaev, Z., Gearhart, S. A., Castro‐Echeverry, E., Aldape, K., Trumble, E. R., & Lehman, N. L. (2025) · Molecular Biology Reports · doi:10.1007/s11033-024-10201-8 · Cited by 4
YAP/TAZ–TEAD link angiogenesis to nutrients
Oberkersch, R. E., & Santoro, M. M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00579-9 · Cited by 4
Mechanobiology of Autophagy: The Unexplored Side of Cancer
Hernández‐Cáceres, M. P., Munoz, L., Pradenas, J., Pena, F., Lagos, P., Aceitón, P., Owen, G. I., Morselli, E., Criollo, A., Ravasio, A., et al. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pacr.1.2021.40 · Cited by 3
Krasniqi, E., Lisa, F. S. D., Benedetto, A. D., Barba, M., Pizzuti, L., Filomeno, L., Ercolani, C., Tinari, N., Grassadonia, A., Santini, D., et al. (2022) · Cancers · doi:10.3390/cancers14194835 · Cited by 3
Zhang, T., Zhou, Q., Jusić, N., Lu, W., Pignoni, F., & Neal, S. J. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151421 · Cited by 3
Ramaiah, M. J., Vasavi, P. J., & Chandana, N. V. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100755 · Cited by 3
Kaur, K. K. (2021) · Acta Scientific Cancer Biology · doi:10.31080/ascb.2021.04.0339 · Cited by 3
Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex
Terry, B. K., Park, R., Cho, S., Crino, P. B., & Kim, S. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab374 · Cited by 3
Pleniceanu, O., Shukrun, R., Omer, D., Vax, E., Kanter, I., Dziedzic, K., Pode‐Shakked, N., Mark‐Danieli, M., Pri‐Chen, S., Gnatek, Y., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708507 · Cited by 3
Autophagy in Ocular Pathophysiology
Mitter, S. K., & Boulton, M. E. (2016) · InTech eBooks · doi:10.5772/64667 · Cited by 2
CCDC115 inhibits autophagy‐mediated degradation of YAP to promote cell proliferation
Feng, H., Liu, X., Zhou, C., Gu, Q., Li, Y., Chen, J., Teng, J., & Zheng, P. (2023) · FEBS Letters · doi:10.1002/1873-3468.14575 · Cited by 2
Rare Case of Renal Epithelioid Angiomyolipoma With Tumor Thrombus Into the IVC and Right Atrium
Xing, L., Yilun, Y., Zheng, J., & Chen, W. (2024) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.016083 · Cited by 2
Andlovic, B., Wolf, A., Hiltmann, M., Klebl, B., Eickhoff, J., & Ottmann, C. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.100191 · Cited by 2
AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth
Kanai, R., McMullan, S., Baniya, P., Dai, R. S., Norton, E., Lasher, K., Purello, C. T., Seavey, C. N., Rubin, B. P., & Lamar, J. M. (2025) · Cancers · doi:10.3390/cancers17172889 · Cited by 2
AP‐1B Controls Several Levels of Cell Proliferation and Differentiation in Mouse Enteroids
Duclos, M., Bourdais, A., Nicolle, O., Helpiquet, A., Michaux, G., & Bidaud-Meynard, A. (2026) · Biology of the Cell · doi:10.1111/boc.70076 · Cited by 2
Sugar, Fat, and YAP: A Recipe for Vascular Stiffness
Mani, A., Hwa, J., & Martin, K. A. (2022) · Circulation Research · doi:10.1161/circresaha.122.320880 · Cited by 2
Neuro-Ophthalmologic Manifestations of Systemic and Intracranial Disease
Brodsky, M. C. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3384-6_11 · Cited by 1
Differentiation and Development of the Bovine Blastocyst
Negrón‐Pérez, V. M. (2017) · PhDT · Cited by 1
Lam, H. C., Baglini, C. V., Lope, A. L., Parkhitko, A. A., Liu, H.-J., Alesi, N., Malinowska, I. A., Ebrahimi‐Fakhari, D., Saffari, A., Yu, J. J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-3417 · Cited by 1
Self-citationSen, S. (2022) · TSpace (University of Toronto) · Cited by 1
Masliantsev, K. (2018) · theses.fr (ABES) · doi:10.70675/ade51a77zd032z4962z8279zcdcfd25488ae · Cited by 1
Gentien, D. (2022) · theses.fr (ABES) · doi:10.70675/5d73d331zeefdz4c42z82c6zeb7214c2247b · Cited by 1
Al-Waili, D. I. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Delaney, S. P. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-24053
Ferri, G., Goffette, V., Porée, E., Braeg, S., Carvalho, S., Quatredeniers, M., Kuehn, E. W., Saunier, S., & Viau, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.17.475784
Effects of Bpaf on Apoptosis and Autophagy of Mice Heart TissuePreprint
Xu, L., Zhang, H., Zhou, J.-S., Shi, J., Jiang, J., Hu, W., Guo, F., Liu, X., & Sun, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4057200
Effect of CLN3-loss-of-function on cellular metabolism and signalling
Więciorek-Płuciennik, K. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9277
YAP as a Regulator of DNA Replication Timing
García, R. M. (2020) · theses.fr (ABES) · doi:10.70675/851164dez278fz4843z9ae1z7883b96c86f2
The role of YAP oncogene in the control of mitochondrial function
Wei, C. (2021) · theses.fr (ABES) · doi:10.70675/205ff903ze3b3z42e8z81eaz198b97b47523
Wu, Z., Song, X., & Song, J. (2024) · International Conference on Biomedical and Bioinformatics Engineering (ICBBE) · doi:10.1145/3707127.3707164
(2019) · Institutional Research Information System (University of Udine)
Metadata
- Authors
- Liang, N., Zhang, C., Dill, P., Panasyuk, G., Pion, D., Koka, V., Gallazzini, M., Olson, E. N., Lam, H., Henske, E. P., Dong, Z., Apte, U., Pallet, N., Johnson, R. L., Terzi, F., Kwiatkowski, D. J., Scoazec, J.-Y., Martignoni, G., & Pende, M.
- Affiliations
- Inserm (FR)
- The University of Texas Southwestern Medical Center (US)
- Brigham and Women's Hospital (US)
- Charlie Norwood VA Medical Center (US)
- University of Kansas Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Hospices Civils de Lyon (FR)
- University of Verona (IT)
- Corresponding author
- Pende, Mario
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2014-10-06
- Volume
- 211
- Issue
- 11
- Pages
- 2249-2263
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4203941
- OpenAlex
- W2111900780
- Cited by
- 205
- References
- 122
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 13 · 2023: 14 · 2022: 23 · 2021: 24 · 2020: 23 · 2019: 24 · 2018: 19 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 1
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Association pour la Recherche sur le Cancer
- Institut National de la Santé et de la Recherche Médicale
- China Scholarship Council
- Institut National Du Cancer
- National Cancer Institute (P01CA120964)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK096556)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- tuberous sclerosis complex, YAP, mTOR, autophagy, Hippo signaling pathway, PEComa, TSC1, TSC2, protein degradation, lysosomes, organ size control, therapeutic target, tumor growth control
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Verteporfin, YAP-Signaling Proteins, Animals, Autophagy, Cell Survival, Disease Models, Animal, Gene Expression Regulation, Humans, Immunohistochemistry, Kidney, Phosphoproteins, Porphyrins, Tuberous Sclerosis, Signal Transduction, Up-Regulation, Apoptosis, Angiomyolipoma, Mice, Knockout, Cell Cycle Proteins, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Cell Proliferation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.